ABSI - Pambiji Buku Bisnis absci.com

Absci (ABSI) relies on external cloud resources to power its neural networks, delegating materials logistics to third-party partners. The company's technological edge is based on the creation of an AI system that accelerates the discovery of therapeutic antibodies. The current metric stands at 0.24. The implementation of software robots in billing and monitoring reduces costs, and the price trajectory shown below visualizes the asset's market dynamics.

Book value separates the real value of a business from the volatility of market quotes. This metric reflects the difference between all assets and liabilities, capturing the net value of equity. By analyzing the history of book capitalization, an investor assesses a company's internal margin of safety. For Absci (ABSI), this foundation is strengthened by its generative AI platform for antibody design. Technological superiority in drug discovery converts into scalable data, increasing the long-term value of assets.